No public evidence summary is available.
GDELT Global Knowledge Graph · 2026-10-10 13:45
View evidence
- MediaGDELT Global Knowledge Graph2026-10-10 13:45View source
Company
Company
No. 98 of 15437top 1%
11 direct links
New links this week
Weighted by public relations with evidence, recomputed daily.
Arrows show the direction of the relationship. Filter to focus on a business area.
expand Everest's presence in the United StatesView source
Everest has built an industry-leading and fully integrated AI+mRNA platform that accelerates mRNA product development.View source
Leveraging its proprietary mRNA platform, the Company is advancing its existing pipelineView source
Leveraging its proprietary AI+mRNA platform, Everest is advancing multiple mRNA therapeutic vaccine and in vivo CAR-T programs across oncology and autoimmune diseases.View source
a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeuticsView source
Everest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative pharmaceutical productsView source
Everest has established and optimized its proprietary LNP delivery system, with patent coverage including ionizable lipids and stealth lipids.View source
Leveraging its proprietary AI+mRNA platform, Everest is advancing multiple mRNA therapeutic vaccine and in vivo CAR-T programs across oncology and autoimmune diseases.View source
The Company's therapeutic areas of focus include autoimmune, ophthalmology, critical care, and CKM (cardiovascular, kidney, and metabolic) diseases.View source
Everest has built an industry-leading and fully integrated AI+mRNA platform that accelerates mRNA product development.View source
Leveraging its proprietary mRNA platform, the Company is advancing its existing pipeline, including mRNA in vivo CAR-T and mRNA cancer vaccinesView source
The Company's therapeutic areas of focus include autoimmune, ophthalmology, critical care, and CKM (cardiovascular, kidney, and metabolic) diseases.View source
Showing 1 to 8 of 18
Read the assertion alongside its sources. Expand a row to inspect the evidence.
No public evidence summary is available.
GDELT Global Knowledge Graph · 2026-10-10 13:45
expand Everest's presence in the United States
GDELT Global Knowledge Graph · PR Newswire news releases · 2026-10-10 13:45
expand Everest's presence in the United StatesView source
Everest has built an industry-leading and fully integrated AI+mRNA platform that accelerates mRNA product development.
GDELT Global Knowledge Graph · PR Newswire news releases · 2026-10-10 13:45
Everest has built an industry-leading and fully integrated AI+mRNA platform that accelerates mRNA product development.View source
Leveraging its proprietary mRNA platform, the Company is advancing its existing pipelineView source
No public evidence summary is available.
GDELT Global Knowledge Graph · 2026-10-10 13:45
No public evidence summary is available.
GDELT Global Knowledge Graph · 2026-10-09 16:15
No public evidence summary is available.
GDELT Global Knowledge Graph · 2026-10-09 12:45
Showing 1 to 6 of 21
Valuation data is available on Pro and Research.
Included in ProNot available: Company signals · Financials · Filings · Guidance